Science Markets
Markets / RNA / Discussion

RNA alone can sustain full replication through serial dilution.

Argue about the evidence, the panel, or whether the hypothesis is worded fairly. The estimate is an AI assessment, not a token price or a settlement verdict. Suggest sources and explain what they change; posting here does not automatically add a source to the evidence packet.

Start a thread

Anyone can post, with or without an account. Automated moderation is off. New posts are marked unmoderated; that is not an endorsement of their claims. You are posting anonymously; no position will be shown beside your name.

No threads yet. The first useful thing anyone can do here is point at a paper the panel has not read.

Read the market first
Weekly AI estimate Unavailable
Back to the market
Locked proposition

An RNA-catalysed system can copy every RNA catalyst needed for its own replication from activated RNA substrates of length <= 3 nucleotides, without protein enzymes, DNA templates or supplied longer sequence-specific fragments. In each of ten consecutive transfers, <= 10% of the prior reaction is retained and the concentration of full-length catalytically active replicase recovers to at least its pre-transfer value. Environmental temperature/pH cycles and a fixed RNA seed at the first transfer are allowed. Transfer count and dilution are operational conventions; this tests a necessary capability of RNA-world models, not Earth's historical origin of life.

Resolution criteria

YES: Two independent laboratories satisfy all ten transfers with sequence-resolved product accounting, catalytic activity and isotope or equivalent tracing demonstrating newly synthesized full-length replicase rather than seed persistence or contamination. NO: A rigorous chemical impossibility result applying to the entire specified substrate/catalyst class, supported by independently verified physical constraints. Failure of one engineered ribozyme or one reaction recipe is not universal disproof; otherwise remain UNDECIDED. Reference sources: QT45 polymerase ribozyme (https://www.science.org/doi/10.1126/science.adt2760); RNA replication with freeze–thaw cycles (https://www.nature.com/articles/s41557-025-01830-y). Evidence policy: use public primary research with methods and uncertainty, plus the named reference sources below. A preprint can inform the estimate but cannot alone meet a terminal criterion; require a peer-reviewed primary result and an independent reproduction using non-overlapping observations or independently prepared samples, unless this is a mathematical proof or the specific criterion instead requires independently implemented calculations. Report data provenance, exclusions, calibration, statistical model and systematic uncertainty. Independence means different data acquisition, not two papers reanalysing the same sample. For a quantitative terminal test, both independent results must meet the stated threshold; disagreement or an interval crossing the boundary means UNDECIDED. Use the final corrected version public at the signed round's evidence cutoff (UTC); exclude later evidence until a later eligible round. Every report in a terminal round must use the same cutoff, covered by the verified signed context and enforced by the configured terminal protocol; a different cutoff requires a new eligible round, never reinterpretation of a signed report or mutation of an immutable binding. This market has no calendar expiry. Retracted findings cannot supply a terminal result. If a named source disappears, use its DOI/publisher or an archived identical version, then an equivalent primary publication applying these unchanged definitions; if none is accessible, remain UNDECIDED, never substitute a different test. Missing data, failed replication, a null search outside the specified domain, or an untested alternative is not automatically NO. These are instructions for evidence assessment, not an automatic truth oracle: scientific interpretation and systematic-error judgment remain. Settlement follows the configured platform mode: terminal mode requires one valid round with all three frozen models returning the same explicit YES or NO and criterion_met=true; any UNDECIDED, failure or disagreement leaves it unresolved. Legacy proposal/challenge mode requires its recorded review process. Model agreement does not prove scientific truth. Invalidity is not NO and this text does not authorize a refund or cancellation: only a cancellation rule disclosed before exposure, if the configured contract supports it, can apply. Otherwise pause new entries and preserve holders' existing rights. Never reinterpret terms after listing.

Read resolution status
Keep it about the science. Posts that try to talk the panel into a position rather than argue from evidence are the exact failure mode this design exists to study.